Bio-Techne Corporation
US ˙ NasdaqGS ˙ US09073M1045

SecurityTECH / Bio-Techne Corporation
InstitutionLPL Financial LLC
Latest Disclosed Ownership62,470 shares
Latest Disclosed Value $ 3,264,683
LPL Financial LLC reports 19.83% decrease in ownership of TECH / Bio-Techne Corporation

On May 6, 2026 - LPL Financial LLC filed a 13F-HR form disclosing ownership of 62,470 shares of Bio-Techne Corporation (US:TECH) valued at $3,264,682 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 77,923 shares of Bio-Techne Corporation. This represents a change in shares of -19.83% during the quarter. The current value of the position is $3,176,600 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F BIO-TECHNE COM 09073M104 62,470 -15,453 -19.83 3,265 -28.76 0.0009
2026-02-11 2025-12-31 13F BIO-TECHNE COM 09073M104 77,923 4,244 5.76 4,583 11.81 0.0013
2025-11-12 2025-09-30 13F BIO-TECHNE COM 09073M104 73,679 -11,518 -13.52 4,099 -6.50 0.0012
2025-08-12 2025-06-30 13F BIO-TECHNE COM 09073M104 85,197 2,129 2.56 4,383 -5.11 0.0015
2025-05-07 2025-03-31 13F BIO-TECHNE COM 09073M104 83,068 1,267 1.55 4,620 -23.48 0.0018
2025-02-11 2024-12-31 13F BIO-TECHNE COM 09073M104 81,801 7,777 10.51 6,037 2.03 0.0025
2024-11-08 2024-09-30 13F BIO-TECHNE COM 09073M104 74,024 5,544 8.10 5,917 20.59 0.0026
2024-08-07 2024-06-30 13F BIO-TECHNE COM 09073M104 68,480 6,070 9.73 4,907 11.68 0.0024
2024-05-10 2024-03-31 13F BIO-TECHNE COM 09073M104 62,410 19,963 47.03 4,393 34.14 0.0024
2024-02-14 2023-12-31 13F BIO-TECHNE COM 09073M104 42,447 2,035 5.04 3,275 20.05 0.0020
2023-11-13 2023-09-30 13F BIO-TECHNE COM 09073M104 40,412 2,363 6.21 2,729 -12.14 0.0019
2023-07-31 2023-06-30 13F BIO-TECHNE COM 09073M104 38,049 1,330 3.62 3,106 13.99 0.0022
2023-05-10 2023-03-31 13F BIO-TECHNE COM 09073M104 36,719 5,018 15.83 2,724 4.13 0.0021
2023-02-07 2022-12-31 13F BIO-TECHNE COM 09073M104 31,701 24,240 324.89 2,616 23.45 0.0022
2022-11-14 2022-09-30 13F BIO-TECHNE COM 09073M104 7,461 -729 -8.90 2,119 -27.16 0.0020
2022-08-12 2022-06-30 13F BIO-TECHNE COM 09073M104 8,190 -1,564 -16.03 2,909 -31.13 0.0028
2022-05-16 2022-03-31 13F BIO-TECHNE COM 09073M104 9,754 205 2.15 4,224 -14.11 0.0036
2022-02-14 2021-12-31 13F BIO-TECHNE COM 09073M104 9,549 413 4.52 4,918 11.14 0.0041
2021-11-15 2021-09-30 13F BIO-TECHNE COM 09073M104 9,136 1,041 12.86 4,425 21.40 0.0042
2021-08-13 2021-06-30 13F BIO-TECHNE COM 09073M104 8,095 2,980 58.26 3,645 86.64 0.0037
2021-05-14 2021-03-31 13F BIO-TECHNE COM 09073M104 5,115 931 22.25 1,953 46.95 0.0022
2021-02-12 2020-12-31 13F BIO-TECHNE COM 09073M104 4,184 663 18.83 1,329 52.41 0.0017
2020-11-09 2020-09-30 13F BIO-TECHNE COM 09073M104 3,521 311 9.69 872 2.83 0.0014
2020-08-13 2020-06-30 13F BIO-TECHNE COM 09073M104 3,210 195 6.47 848 48.25 0.0015
2020-05-14 2020-03-31 13F BIO-TECHNE COM 09073M104 3,015 5 0.17 572 -12.94 0.0012
2020-02-14 2019-12-31 13F BIO TECHNE COM 09073M104 3,010 -147 -4.66 657 6.31 0.0012
2019-11-13 2019-09-30 13F BIO TECHNE COM 09073M104 3,157 80 2.60 618 -3.89 0.0013
2019-08-09 2019-06-30 13F BIO TECHNE COM 09073M104 3,077 243 8.57 643 13.81 0.0014
2019-05-08 2019-03-31 13F BIO TECHNE COM 09073M104 2,834 203 7.72 565 48.29 0.0013
2019-02-07 2018-12-31 13F BIO TECHNE COM 09073M104 2,631 -282 -9.68 381 -35.97 0.0010
2018-11-14 2018-09-30 13F BIO TECHNE COM 09073M104 2,913 -121 -3.99 595 32.52 0.0014
2018-08-14 2018-06-30 13F BIO TECHNE COM 09073M104 3,034 -38 -1.24 449 -1.97 0.0012
2018-05-15 2018-03-31 13F BIO TECHNE COM 09073M104 3,072 551 21.86 458 40.92 0.0013
2018-02-14 2017-12-31 13F BIO TECHNE COM 09073M104 2,521 -25 -0.98 325 2.85 0.0010
2017-11-14 2017-09-30 13F BIO TECHNE COM 09073M104 2,546 198 8.43 316 14.91 0.0011
2017-08-14 2017-06-30 13F BIO TECHNE COM 09073M104 2,348 2,348 275 0.0010
2016-11-16 2016-09-30 13F BIO TECHNE COM 09073M104 0 -3,189 -100.00 0 -100.00
2016-08-15 2016-06-30 13F BIO TECHNE COM 09073M104 3,189 3,189 360 0.0030
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.